6:12 PM
 | 
Oct 27, 2009
 |  BC Extra  |  Company News

Ligand to acquire Metabasis

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) will acquire Metabasis Therapeutics Inc. (NASDAQ:MBRX) for $3.2 million in cash. Metabasis shareholders will receive about $1.8 million, which is net of Metabasis' liabilities at closing. Metabasis stockholders also will receive contingent value rights entitling them to future cash...

Read the full 205 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >